ARCHIVES

Ivax Paclitaxel To Remain On Market In Deal With BMS.

This article is from The Cancer Letter archive.

Vol. 28 No. 05 | February 1, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Brinkley Asks Subcommittee to Add $62.5 Million To NCI Budget for Unfunded Grants

May 11, 1979

AHRQ Funds Research To Reduce Medical Errors.

October 19, 2001

In Brief: Breast Cancer Projects To Pay For Concurrent Pathology Review; Laetrile Study Entry Closed

May 19, 1978

NCI Provides $40 Million To Four Centers For Cancer Communications Research.

June 27, 2003

High Vitamin E Consumption Can Lower Liver Cancer Risks

July 27, 2012

Emory Executive Objects to Report On Merit review

July 22, 1977